61

Austar Lifesciences LtdHKG 6118 Stock Report

Last reporting period 30 Jun, 2023

Updated 19 Sep, 2024

Last price

Market cap $B

0.036

Micro

Exchange

XHKG - Hong Kong Exchange

6118.HK Stock Analysis

61

Uncovered

Austar Lifesciences Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

1/100

Low score

Market cap $B

0.036

Dividend yield

1.53 %

Shares outstanding

512.58 B

Austar Lifesciences Ltd. operates as an investment holding company. The company is headquartered in Beijing, Beijing and currently employs 1,785 full-time employees. The company went IPO on 2014-11-07. The firm operates its business through six segments: liquid and bioprocess system segment, clean room and automation control and monitoring system segment, powder and solid system segment, good manufacturing practice (GMP) compliance service segment, life science consumables segment and distribution and agency of pharmaceutical equipment segment.

View Section: Eyestock Rating